Conditions: Migraine Headache
Keywords: migraine headache Botulinum Toxin Type A BOTOX BTX-A
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
The purposes of this study are to assess whether subjects treated with BOTOX will:

1. have a decrease in the frequency and intensity of migraine headaches
2. experience improvements in quality of life
3. experience a reduction in the frequency of health care services obtained.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Botulinum Toxin Type A
Intervention descriptions: intervention 1: 100 Units - Dilution: 25U/ml (4:1 BOTOX/preservative free saline)

Protocol document: